Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics.

MLA

Liu, Mohan, et al. “Aromatase Inhibitor-Associated Bone Fractures: A Case-Cohort GWAS and Functional Genomics.” Molecular Endocrinology (Baltimore, Md.), vol. 28, no. 10, Oct. 2014, pp. 1740–51. EBSCOhost, https://doi.org/10.1210/me.2014-1147.

APA

Liu, M., Goss, P. E., Ingle, J. N., Kubo, M., Furukawa, Y., Batzler, A., Jenkins, G. D., Carlson, E. E., Nakamura, Y., Schaid, D. J., Chapman, J.-A. W., Shepherd, L. E., Ellis, M. J., Khosla, S., Wang, L., & Weinshilboum, R. M. (2014). Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics. Molecular Endocrinology (Baltimore, Md.), 28(10), 1740–1751. https://doi.org/10.1210/me.2014-1147

Chicago

Liu, Mohan, Paul E Goss, James N Ingle, Michiaki Kubo, Yoichi Furukawa, Anthony Batzler, Gregory D Jenkins, et al. 2014. “Aromatase Inhibitor-Associated Bone Fractures: A Case-Cohort GWAS and Functional Genomics.” Molecular Endocrinology (Baltimore, Md.) 28 (10): 1740–51. doi:10.1210/me.2014-1147.